Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2024 Sep 6;7(1):237.
doi: 10.1038/s41746-024-01232-3.

Navigating the EU AI Act: implications for regulated digital medical products

Affiliations

Navigating the EU AI Act: implications for regulated digital medical products

Mateo Aboy et al. NPJ Digit Med. .

Abstract

The newly adopted EU AI Act represents a pivotal milestone that heralds a new era of AI regulation across industries. With its broad territorial scope and applicability, this comprehensive legislation establishes stringent requirements for AI systems. In this article, we analyze the AI Act’s impact on digital medical products, such as medical devices: How does the AI Act apply to AI/ML-enabled medical devices? How are they classified? What are the compliance requirements? And, what are the obligations of ‘providers’ of these AI systems? After addressing these foundational questions, we discuss the AI Act’s broader implications for the future of regulated digital medical products.

PubMed Disclaimer

Conflict of interest statement

The authors declare no competing interests.

References

    1. Aboy, M., Price, W. N. 2nd & Raker, S. Mapping the patent landscape of medical machine learning. Nat. Biotechnol.41, 461–468 (2023). 10.1038/s41587-023-01735-6 - DOI - PubMed
    1. FDA. Artificial Intelligence and Machine Learning (AI/ML)-Enabled Medical Devices. https://www.fda.gov/medical-devices/software-medical-device-samd/artific... (2022).
    1. Aboy, M., Crespo, C. & Stern, A. D. Beyond the 510(k): The regulation of novel moderate-risk medical devices, intellectual property considerations, and innovation incentives in the FDA’s De Novo pathway. NPJ Digit Med.24, 1–8 (2024). - PMC - PubMed
    1. in Regulation (EU) 2017/745 of the European Parliament and of the Council of 5 April 2017 on medical devices. (ed European Parliament and Council) (2017).
    1. in Regulation of the European Parliament and of the Council laying down harmonised rules on Artificial Intelligence (Artificial Intelligence Act) (ed European Parliament and Council) (2024).

LinkOut - more resources